These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23788687)

  • 1. Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget's disease.
    Grasemann C; Schündeln MM; Hövel M; Schweiger B; Bergmann C; Herrmann R; Wieczorek D; Zabel B; Wieland R; Hauffa BP
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3121-6. PubMed ID: 23788687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene).
    Polyzos SA; Singhellakis PN; Naot D; Adamidou F; Malandrinou FC; Anastasilakis AD; Polymerou V; Kita M
    J Clin Endocrinol Metab; 2014 Mar; 99(3):703-7. PubMed ID: 24433001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation.
    Saki F; Karamizadeh Z; Nasirabadi S; Mumm S; McAlister WH; Whyte MP
    J Bone Miner Res; 2013 Jun; 28(6):1501-8. PubMed ID: 23322328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Denosumab as the potent therapeutic agent against Paget's disease of bone].
    Hirao M; Hashimoto J
    Clin Calcium; 2011 Aug; 21(8):1231-8. PubMed ID: 21814030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile Paget's disease: the second reported, oldest patient is homozygous for the TNFRSF11B "Balkan" mutation (966_969delTGACinsCTT), which elevates circulating immunoreactive osteoprotegerin levels.
    Whyte MP; Singhellakis PN; Petersen MB; Davies M; Totty WG; Mumm S
    J Bone Miner Res; 2007 Jun; 22(6):938-46. PubMed ID: 17352649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhizomelia and Impaired Linear Growth in a Girl with Juvenile Paget Disease: The Natural History of the Condition.
    Höppner J; Steff K; Lobert F; Heyer CM; Hauffa BP; Grasemann C
    Horm Res Paediatr; 2021; 94(3-4):151-158. PubMed ID: 34261073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
    Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
    Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7).
    Whyte MP; Campeau PM; McAlister WH; Roodman GD; Kurihara N; Nenninger A; Duan S; Gottesman GS; Bijanki VN; Sedighi H; Veis DJ; Mumm S
    Bone; 2020 Aug; 137():115364. PubMed ID: 32298837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Wensel TM; Iranikhah MM; Wilborn TW
    Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
    Body JJ; Facon T; Coleman RE; Lipton A; Geurs F; Fan M; Holloway D; Peterson MC; Bekker PJ
    Clin Cancer Res; 2006 Feb; 12(4):1221-8. PubMed ID: 16489077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
    Dempster DW; Lambing CL; Kostenuik PJ; Grauer A
    Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paget's disease of the bone after treatment with Denosumab: a case report.
    Schwarz P; Rasmussen AQ; Kvist TM; Andersen UB; Jørgensen NR
    Bone; 2012 May; 50(5):1023-5. PubMed ID: 22586699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy.
    Cundy T; Wheadon L; King A
    J Bone Miner Res; 2004 May; 19(5):703-11. PubMed ID: 15068492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.
    Whyte MP; Tau C; McAlister WH; Zhang X; Novack DV; Preliasco V; Santini-Araujo E; Mumm S
    Bone; 2014 Nov; 68():153-61. PubMed ID: 25063546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab in postmenopausal women with low bone mineral density.
    McClung MR; Lewiecki EM; Cohen SB; Bolognese MA; Woodson GC; Moffett AH; Peacock M; Miller PD; Lederman SN; Chesnut CH; Lain D; Kivitz AJ; Holloway DL; Zhang C; Peterson MC; Bekker PJ;
    N Engl J Med; 2006 Feb; 354(8):821-31. PubMed ID: 16495394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Paget's Disease of Bone with Denosumab: Case Report and Literature Review.
    Reid IR; Sharma S; Kalluru R; Eagleton C
    Calcif Tissue Int; 2016 Sep; 99(3):322-5. PubMed ID: 27193832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paget's disease of bone: new therapeutic strategies].
    D'Amore M; Lisi S; Sisto M; De Marino AV
    Recenti Prog Med; 2013 Mar; 104(3):89-92. PubMed ID: 23548950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokines in bone diseases. Osteoprotegerin and juvenile Paget's disease].
    Hosogane N; Miyamoto T
    Clin Calcium; 2010 Oct; 20(10):1540-4. PubMed ID: 20890037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.
    Cremers S; Garnero P
    Drugs; 2006; 66(16):2031-58. PubMed ID: 17112299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab for the treatment of bone metastases in advanced breast cancer.
    Casas A; Llombart A; Martín M
    Breast; 2013 Oct; 22(5):585-92. PubMed ID: 23759273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.